Cite
HARVARD Citation
Allez, M. et al. (n.d.). P377 Impact of moderate-to-severe endoscopic disease criteria on endoscopic response, endoscopic remission, and deep remission in patients receiving ustekinumab or adalimumab in the SEAVUE study. Journal of Crohn's and colitis. pp. i379-i380. [Online].